Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HU6 in Subjects With Elevated Liver Fat and High Body Mass Index
NCT04874233Phase 2Completed
- Sponsor
- Rivus Pharmaceuticals, Inc.
- Start
- Apr 2021
- Primary completion
- Nov 2021
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HU6 in Nonalcoholic steatohepatitis (NASH), obesity, sponsored by Rivus Pharmaceuticals, Inc.. Started Apr 2021; status: completed.
02
Drugs
HU6
03
Conditions
Nonalcoholic steatohepatitis (NASH)obesity
Beyond the preview
Go deeper on NCT04874233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04874233.